3 completed. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 1 | Completed 1 |
Follow Myxofibrosarcoma: new trials by email Literature Review of Myxofibrosarcoma trials Research Report on Myxofibrosarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas DCC-3014, Avelumab - Sarcoma, Advanced Sarcoma | Phase 1 | Completed | Memorial Sloan Kettering Cancer Center | 32 | 2020-01-22 | 2025-08-28 |
| CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With Sarcoma CAB-AXL-ADC, PD-1 inhibitor - Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma | Phase 1 / Phase 2 | Completed | BioAtla, Inc. | 245 | 2018-02-15 | 2025-09-23 |
| Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery Doxorubicin Hydrochloride, Laboratory Biomarker Analysis, Pharmacological Study - Advanced Soft Tissue Sarcoma, Locally Advanced Angiosarcoma | Phase 1 | Completed | OHSU Knight Cancer Institute | 16 | 2017-03-10 | 2023-08-16 |
Dermatofibrosarcoma (3) · Histiocytoma, Malignant Fibrous (3) · Liposarcoma (2) · Sarcoma (2) · Disorders of Sex Development (1) · Fibrosarcoma (1) · Hemangiosarcoma (1) · Leiomyosarcoma (1) · Neoplasms (1) · Neurofibrosarcoma (1) · Sarcoma, Synovial (1)
Histiocytoma (3) · Neoplasms by Histologic Type (3) · Neoplasms, Connective Tissue (3) · Neoplasms, Connective and Soft Tissue (3) · Neoplasms, Fibrous Tissue (3) · Fibrosarcoma (2) · Neoplasms (2) · Neoplasms, Adipose Tissue (2) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Endocrine System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Gonadal Disorders (1) · Male Urogenital Diseases (1)
Doxorubicin (1) · Immune Checkpoint Inhibitors (1) · avelumab (1) · ribociclib (1)
BioAtla, Inc. (1) · Memorial Sloan Kettering Cancer Center (1) · OHSU Knight Cancer Institute (1)
United States (3) · Hong Kong (1) · Taiwan (1)
Lara E Davis (1) · Sandra D'Angelo, MD (1)